Quantessence Capital LLC Clear Point Neuro, Inc. Transaction History
Quantessence Capital LLC
- $400 Billion
- Q1 2025
A detailed history of Quantessence Capital LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Quantessence Capital LLC holds 15,582 shares of CLPT stock, worth $190,100. This represents 0.05% of its overall portfolio holdings.
Number of Shares
15,582Holding current value
$190,100% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
105Shares Held
8.14MCall Options Held
243KPut Options Held
30.2K-
Vanguard Group Inc Valley Forge, PA1.28MShares$15.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny741KShares$9.04 Million0.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA482KShares$5.88 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$4.47 Million0.0% of portfolio
-
Brown Advisory Inc331KShares$4.04 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $299M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...